Update on Detection of the latest SARS-CoV-2 Variant
Singapore, April 11, 2023 – Update on Detection of the latest SARS-CoV-2 Variant Credo Diagnostics Biomedical Pte Ltd continues the post-market monitoring of the reliability of our assays. We have performed nucleotide analysis using BLASTn analysis comparing primers and probes of the assays involving SARS-CoV-2 virus detection to the sequences listed in GISAID from January […]
